| http://www.w3.org/ns/prov#value | - These and other risks, including those related to the results of discovery research and preclinical testing; the manufacture of antibodies under cGMP requirements; the timing or results of pending and future clinical trials (including the design and progress of clinical trials; safety and efficacy of the products being tested; action, inaction or delay by the FDA, European or other regulators or t
|
